Julio Rosenstock

105PUBLICATIONS

178CO-AUTHORS

Epidemiological modellingOncology and carcinogenesis not elsewhere classifiedEpigenetics (incl. genome methylation and epigenomics)PharmacogenomicsComputing education

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (105)

Sort by Publication Date:

|Jul 02, 2026

Potential Mediators of Efpeglenatide's Cardiovascular Benefit: An Exploratory Analysis of the AMPLITUDE-O Trial.

|Jun 24, 2026

Publisher Correction: Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial.

|Jun 15, 2026

Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial.

|Jun 05, 2026

Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial.

|Jun 05, 2026

Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.

|May 22, 2026

Simplified Switching to Once-Weekly Insulin Icodec Without an Initial One-Time Additional Dose Versus Once-Daily Insulin Glargine U100 in Basal Insulin-Treated Type 2 Diabetes (ONWARDS 10): A Randomised Controlled Trial.

Pageof 18

Frequent Collaborators

11 joint publications

Stefano Del Prato

10 joint publications

Vanita R Aroda

10 joint publications

Rajiv Agarwal

10 joint publications

Hiddo J L Heerspink

10 joint publications

Ildiko Lingvay

Peter Rossing

Muthiah Vaduganathan

Juan Pablo Frias

Lawrence Blonde

Masaomi Nangaku

Frequent Collaborators

11 joint publications

Stefano Del Prato

10 joint publications

Vanita R Aroda

10 joint publications

Rajiv Agarwal

10 joint publications

Hiddo J L Heerspink